8 research outputs found
Building ProteomeTools based on a complete synthetic human proteome.
We describe ProteomeTools, a project building molecular and digital tools from the human proteome to facilitate biomedical research. Here we report the generation and multimodal liquid chromatography-tandem mass spectrometry analysis of \u3e330,000 synthetic tryptic peptides representing essentially all canonical human gene products, and we exemplify the utility of these data in several applications. The resource (available at http://www.proteometools.org) will be extended to \u3e1 million peptides, and all data will be shared with the community via ProteomicsDB and ProteomeXchange
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partial (CRS2), and no/minimal (CRS1) response after neoadjuvant chemotherapy (NACT). Our aim was to review current evidence to determine whether the CRS is prognostic in women with tubo-ovarian HGSC treated with NACT.This article is freely available via Open Access. Click on the Publisher URL to access the full-text via the publisher's site
Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials
BACKGROUND: The lack of a consensus definition of neonatal sepsis and a core outcome set (COS) proves a substantial
impediment to research that influences policy and practice relevant to key stakeholders, patients and parents.
METHODS: A systematic review of the literature was performed according to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines. In the included studies, the described outcomes were extracted in accordance with the
provisions of the Core Outcome Measures in Effectiveness Trials (COMET) handbook and registered.
RESULTS: Among 884 abstracts identified, 90 randomised controlled trials (RCTs) were included in this review. Only 30 manuscripts
explicitly stated the primary and/or secondary outcomes. A total of 88 distinct outcomes were recorded across all 90 studies included.
These were then assigned to seven different domains in line with the taxonomy for classification proposed by the COMET initiative.
The most frequently reported outcome was survival with 74% (n = 67) of the studies reporting an outcome within this domain.
CONCLUSIONS: This systematic review constitutes one of the initial phases in the protocol for developing a COS in neonatal sepsis.
The paucity of standardised outcome reporting in neonatal sepsis hinders comparison and synthesis of data. The final phase will
involve a Delphi Survey to generate a COS in neonatal sepsis by consensus recommendation